尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Vasista Vittal, 首席财务官. Officer active across 1 company, notably REGENXBIO Inc.. Cumulatively, 11 reports have been recorded. Split: 0 buy · 4 sells. Total volume traded: €289k. History available since 27 July 2021. The latest transaction was disclosed on 19 March 2024 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
Vasista Vittal is Chief Financial Officer at REGENXBIO Inc. He has 11 filings in total, and across the recent filings tracked, the transactions cover the period from 2021-07-29 to 2024-03-21, with EUR 0 of buys and EUR 288719 of sells, the most common transaction nature being Option exercise.